The broader divide between federal and state marijuana policy remains largely intact, leaving states to navigate a fragmented landscape with few clear answers about what comes next.
The U.S. Department of Justice’s recent decision to downgrade the drug classification for medical cannabis will help medical marijuana businesses. Companies will be able to…
